Effects of Black Cohosh on Menopausal Hot Flashes
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00010712 |
Recruitment Status :
Completed
First Posted : February 5, 2001
Last Update Posted : August 18, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Postmenopause Hot Flashes Osteoporosis, Postmenopausal | Drug: Black Cohosh | Phase 2 |
Most American women will spend the last third of their lives post-menopause. During this time, chronically low levels of steroidal estrogens may lead to a number of short and long-term medical sequelae such as hot flashes, vaginal dryness, heart disease, and osteoporosis. While some physicians believe that demonstrated beneficial effects of estrogen, particularly on the cardiovascular and skeletal systems, warrant the taking of hormone therapy from menopause on, many women choose not to take estrogen replacement therapy (ERT) and are increasingly exploring alternative approaches to ERT.
For centuries, black cohosh (Cimicifuga racemosa) has been used worldwide for women's health. Despite its long-standing use, studies of black cohosh have yielded conflicting data, in part because of lack in study design rigor and the short duration of studies to date. The primary aim of this study is to correct past shortcomings in study design to determine whether treatment with black cohosh is effective in treating menopausal symptoms.
Participants in this study will be given black cohosh for a 12-month period. Potential mechanisms of action of black cohosh will be examined by quantifying the levels of sex hormones, including estradiol, estrone, FSH, and LH. Because black cohosh may act as an estrogenic agent, the effect on endometrium will be evaluated by sonogram and by monitoring the incidence of adverse events and compliance with the study.
Study Type : | Interventional (Clinical Trial) |
Allocation: | Randomized |
Primary Purpose: | Treatment |
Official Title: | Effects of Black Cohosh on Menopausal Hot Flashes |
Study Start Date : | September 1999 |
Study Completion Date : | July 2005 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 45 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Resident of the New York Metro Area
- Postmenopausal
- Weight within 90% to 120% of ideal body weight

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00010712
United States, New York | |
Columbia University Rosenthal Center for CAM | |
New York, New York, United States, 10032 |
Principal Investigator: | Dr. Fredi Kronenberg | Columbia University |
ClinicalTrials.gov Identifier: | NCT00010712 |
Obsolete Identifiers: | NCT00009386 |
Other Study ID Numbers: |
P50AT000090-01P3 ( U.S. NIH Grant/Contract ) P50AT000090-01 ( U.S. NIH Grant/Contract ) |
First Posted: | February 5, 2001 Key Record Dates |
Last Update Posted: | August 18, 2006 |
Last Verified: | August 2006 |
Menopause Hot Flashes Osteoporosis Postmenopausal |
Osteoporosis Osteoporosis, Postmenopausal Hot Flashes Bone Diseases, Metabolic |
Bone Diseases Musculoskeletal Diseases Metabolic Diseases |